- Robust Financial Health: Crocs maintains a strong balance sheet with a low debt-to-equity ratio of 0.28 and a healthy current ratio of 1.67, indicating solid liquidity.
- Exceeding Market Expectations: The company reported strong Q1 revenue of $921.5 million and adjusted earnings per share of $2.99, both surpassing Wall Street forecasts.
- Positive Outlook: Driven by significant Direct-to-Consumer (DTC) sales growth, Crocs has raised its full-year 2026 adjusted EPS guidance to a range of $13.20 to $13.75.
Crocs, Inc. (NASDAQ: CROX) is a major player in the casual footwear market. The company is a globally recognized footwear brand for its unique foam clogs. It designs, develops, and sells footwear and accessories for men, women, and children under the Crocs and HEYDUDE brand names.
The company’s financial health shows a low debt-to-equity ratio of 0.28, meaning Crocs has less debt compared to shareholder equity. A current ratio of 1.67 suggests Crocs has enough short-term assets to cover its short-term liabilities, indicating good liquidity.
On April 30, 2026, Crocs announced its quarterly earnings report with mixed results. The company reported strong revenue for the quarter at $921.5 million. This figure surpassed the Wall Street forecast of $900.9 million, as highlighted by Proactive Investors, showing better-than-expected sales performance.
Regarding earnings, Crocs posted an adjusted earnings per share of $2.99, which beat the Zacks Consensus Estimate of $2.78. However, this was a slight decrease from the $3.00 per share reported in the same quarter a year ago, reflecting a mixed profit picture.
The revenue performance was driven by a 12.1% year-over-year increase in its Direct-to-Consumer (DTC) sales. This growth was contrasted by a 9.9% decline in its wholesale revenues, showing a shift in the company’s sales channels.
Following the strong quarter, Crocs raised its full-year 2026 guidance. The company now anticipates adjusted earnings per share to be in the range of $13.20 to $13.75. This signals management’s positive investor outlook for the remainder of the year.
